In light of these findings, it is plausible to suggest that sncRNAs may contribute to the development and progression of hypopharyngeal carcinoma by modulating the expression of FOS, thereby mediating the MAPK signaling pathway. The gene discussed is FOS; the disease is hypopharyngeal carcinoma.